Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Clinical trial NCT00831766 · COMPLETED
Trial details
- NCT number
- NCT00831766
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-25
- Primary completion
- 2015-02-17
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.